Passa al contenuto
Merck

3013

Transcreener® ADP2 FI Assay

Sinonimo/i:

ADP Assay Kit, Transcreener ADP Assay

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione

Informazioni su questo articolo

NACRES:
NA.84
UNSPSC Code:
41122100
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


shipped in

dry ice

storage temp.

−20°C

General description

The Transcreener® HTS Assay platform overcomes the need for time-consuming, one-off assay development for individual members within a group transfer enzyme family by utilizing a single set of assay reagents that detect an invariant product. The generic nature of the Transcreener® HTS Assay platform eliminates delays involved in assay development for new HTS targets, and greatly simplifies compound and inhibitor profiling across multiple target families.

The Transcreener® ADP2 fluorescent intensity (FI) assay extends the Transcreener® platform for ADP detection by utilizing a simple fluorescent intensity output which can be used on both fluorescence readers typically found in academic and therapeutic research labs as well as more complex multimode plate readers more commonly used in core facilities and HTS labs. The Transcreener® ADP2 FI Assay is a red, competitive fluorescence intensity (FI) assay based on the detection of ADP and therefore is compatible with any enzyme class that produces ADP, including protein, lipid, and carbohydrate kinases, ATPases, DNA helicases, carboxylases and glutamine synthetase. The Transcreener® ADP2 Assay is a simple one step homogenous detection assay, and is flexible with regard to ATP concentration (0.1 to 100 μM ATP). The assay provides excellent signal at low substrate conversion, with a Z′ = 0.7 at 2.5% ATP conversion using 1 μM ATP.

The Transcreener® ADP2 FI Assay was developed to follow the progress of any enzyme that produces ADP. The Transcreener® ADP Detection Mixture comprises a quenched ADP Alexa594 Tracer bound to the ADP2 monoclonal antibody conjugated to an IRDye® QC-1 quencher licensed from LI-COR®. The tracer is displaced by ADP, the invariant product generated during an enzyme reaction. The displaced tracer becomes un-quenched in solution leading to a positive increase in fluorescence intensity. Therefore, ADP production is proportional to an increase in fluorescence. The red tracer minimizes interference from fluorescent compounds and light scattering.

View full Transcreener® product list

Physical form

Kit with buffered aqueous solutions

Preparation Note

3013-A = 200 assay, 96-well
3013-1K = 1,000 assay, 384-well
3013-10K = 10,000 assay, 384-well

Legal Information

IRDye is a registered trademark of LI-COR, Inc.
LI-COR is a registered trademark of LI-COR, Inc.
Transcreener is a registered trademark of BellBrook Labs


pictograms

Health hazardExclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2 - STOT RE 2 Inhalation

Classe di stoccaggio

12 - Non Combustible Liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

target_organs

Respiratory Tract



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti



Siwen Bi et al.
Polymers, 12(2) (2020-02-07)
In this work, biodegradable polymers were melt compounded with urea phosphate to fabricate "smart fertilizers" for sustainable agriculture. Urea phosphate (UP) is typically applied as a water-soluble fertilizer to treat phosphorus deficiency in high pH soils. Due to the low
Sungsoon Fang et al.
Nature medicine, 21(2), 159-165 (2015-01-07)
The systemic expression of the bile acid (BA) sensor farnesoid X receptor (FXR) has led to promising new therapies targeting cholesterol metabolism, triglyceride production, hepatic steatosis and biliary cholestasis. In contrast to systemic therapy, bile acid release during a meal
Elizabeth Londoño-Velasco et al.
Biomedica : revista del Instituto Nacional de Salud, 39(3), 464-477 (2019-10-05)
Introduction: The exposure to organic solvents and paints has been associated with genotoxicity and a greater risk of neoplasms. However, the type of DNA damage induced in humans by the exposure to these compounds, which would help explain the mechanisms



Numero articolo commerciale globale

SKUGTIN
259225-25G04061835554829
103091002504022536039688
103091010004022536039695
D7766-100G04061833588826
D7766-25G04061833588840
259225-100G04061826075241
D7766-10G04061833588833
33152-10G04061826728185
33152-100G04061826728161
3013-A04061835357017
3013-1K04061835356904
3013-10K04061835357000